Comment on “Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC”
Comment on “Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC”. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S0190962226030793?dgcid=rss_sd_all
Comment on “Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC”. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S0190962226030793?dgcid=rss_sd_all
“Comment on “Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC”.” Journal of the American Academy of Dermatology.
@article{article55992,
title = {Comment on “Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC”},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S0190962226030793?dgcid=rss_sd_all}
}